Continuous Erector Spinae Plane Block or Thoracic Epidural Analgesia Following Video Assisted Thoracic Surgery
Lung Diseases
About this trial
This is an interventional treatment trial for Lung Diseases focused on measuring Video assisted thoracic surgery, Postoperative pain management, Erector spina plane block, Thoracic epidural analgesia
Eligibility Criteria
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) classification I-II
- Scheduled for lVATS under general anesthesia
Exclusion Criteria:
- Bleeding diathesis
- Receiving anticoagulant treatment
- Known local anesthetics and opioid allergy
- Infection of the skin at the site of the needle puncture
- Pregnancy or lactation
- Patients who do not accept the procedure
Sites / Locations
- Istanbul Medipol University Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Group ESPB = Erector spinae plane block group
Group TEA = Thoracic epidural analgesia group
ESP block (Group ESP) will be performed in the preoperative block room.A continuous infusion of 0.125% bupivacaine at the rate of 4 ml/h infusion dose, 6 ml bolus dose and 30 min lockout time will be performed till 48 h postoperative period.
TEA will be performed in the preoperative block room.A continuous infusion of 0.125% bupivacaine at the rate of 4 ml/h infusion dose, 6 ml bolus dose and 30 min lockout time will be performed till 48 h postoperative period.